Brief: NovaBay Pharmaceuticals, Inc. Q2 net income USD -2.036 million
10/08/2023 22:11
Aug 10 (Reuters) - NovaBay Pharmaceuticals, Inc. Q2 gross profit USD 2.306 million. * Q2 operating expenses USD 3.661 million * Q2 operating income USD -1.355 million * Q2 net income USD -2.036 million * Q2 EPS USD -1.27
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing